Breaking Barriers

to Clinical Trials

Diversity & Inclusion

Patient Recruitment & Engagement Advisor l

Published Clinical Data Storyteller l Global Citizen

Bernice

Ofori, MPH

PUBLICATIONS FEATURED ON :

Improving Diversity Enrollment in Clinical Research

I’m Bernice Ofori, MPH, and I’m committed to transforming clinical trials by addressing the systemic barriers and mistrust that have excluded communities of color.

I’ve worked directly with communities, health systems, providers, and a variety of organizations to spread validated insight into improving health outcomes. Through my work in clinical trials, I’ve turned complex clinical research data into compelling narratives, highlighting the need for inclusive research through data storytelling. I’ve collaborated with other clinicians and researchers to build tangible tools that adjust risk stratification and expand the way providers partner with patients to make shared treatment decisions.

DOWNLOAD MY RESUME

A Journey Rooted in Personal Experience

I am Bernice Ofori, MPH, and my journey in public health is deeply personal. Born and raised in Ghana, my life changed forever when I lost my father at an early age. That loss ignited a passion in me to ensure no other family endures the same hardship due to a lack of access to quality healthcare.

Charting the Course for our Next Generation of Global Leaders

Being the first in my family to attend college was a significant challenge. My siblings and I overcame obstacles like limited resources and the complexities of navigating university applications in the U.S. Motivated by the desire to create a better future for ourselves and others often overlooked by the system, we persevered.

This resilience has shaped my approach in public health and clinical trials, where understanding and addressing the unique cultural challenges faced by communities of color is essential to driving equitable healthcare outcomes.

In addition to my work in clinical research, I am passionate about mentoring younger leaders, particularly those in economically disadvantaged countries. I aim to empower future leaders in public health by equipping them to overcome systemic barriers and advocate for their communities. I believe that investing in these emerging leaders is crucial to fostering sustainable change and improving healthcare access worldwide.

Building Solutions

With Communities

My career has been centered around bridging the gaps between access and opportunity in healthcare. I believe that everyone deserves the chance to benefit from medical advancements, and I’ve seen firsthand how engaging the community opens pathways for better outcomes.

Creating Lasting Change for

Underserved Communities

What drives me is the deep understanding of the cultural and systemic barriers that many communities face when it comes to healthcare. My ability to connect on a human level, build trust, and foster real relationships within these communities is what sets me apart. My work is not just about meeting diversity requirements—it's about making real, life-saving changes.

I’m committed to improving health outcomes for marginalized populations, ensuring that every individual has the opportunity to benefit from the advancements in healthcare that they deserve.

My Insights Have Been Featured In:

Mission

& Vision

The impact of losing my father due to a lack of access to quality medical resources, has deeply influenced my life’s mission. That experience shaped my understanding of the real barriers many face in receiving proper medical care, and it continues to fuel my commitment to building solutions that help cross the divide.

Through community engagement and data-driven insights, I work alongside those who need access to care the most. I founded Bridge to Access to ensure that no one has to navigate their healthcare journey alone, and that every person—especially those historically overlooked—has a voice in shaping the future of medicine.

Why Is It Important?

Research has demonstrated that many groups underrepresented and excluded in clinical research can have distinct disease presentations or health circumstances that affect how they

will respond to an investigational drug or therapy. Such differences contribute to variable therapeutic responses and necessitate targeted efficacy and safety evaluation.